FDA Inspection 1100480 — Amer Al-Karadsheh
The FDA completed an inspection of Amer Al-Karadsheh on Jul 31, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 31, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional details
Clinical Investigator (CI)